UPDATE: UBS Downgrades Momenta Pharmaceuticals (MNTA) to Neutral; Negative Court Ruling
Tweet Send to a Friend
(Updated - July 20, 2012 12:34 PM EDT)
UBS downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Buy to Neutral. PT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Buy to Neutral. PT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
